Shares of Mettler-Toledo International, Inc. (NYSE: MTD - Get Free Report) reached a new 52-week high on Tuesday. The stock traded as high as $1,585.72 and last traded at $1,552.22, with a volume of 6800 shares. The stock had previously closed at $1,541.63. Wall Street Analyst Weigh In Several research firms have recently weighed in on
Mettler-Toledo International (NYSE: MTD - Get Free Report) and Codexis (NASDAQ: CDXS - Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, profitability and analyst recommendations. Volatility and Risk Mettler-Toledo International has a beta of
Mettler-Toledo International (NYSE: MTD - Get Free Report) and Personalis (NASDAQ: PSNL - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings. Profitability This table compares Mettler-Toledo International and Personalis' net
Bank of America Corp DE purchased a new position in shares of Mettler-Toledo International, Inc. (NYSE: MTD) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 188,505 shares of the medical instruments supplier's stock, valued at approximately $240,817,000. Bank of America
California State Teachers Retirement System grew its position in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 114,807.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 35,100,865 shares of the medical instruments supplier's stock after buying an additional 35,070,318 shares during
Bank of Nova Scotia purchased a new stake in Mettler-Toledo International, Inc. (NYSE: MTD) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 3,306 shares of the medical instruments supplier's stock, valued at approximately $4,223,000. A number of other hedge funds have also
Mettler-Toledo (MTD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
The transaction involved the disposition of 417 shares valued at $601,000, based on a weighted-average execution price of $1,440.41 per share. Salice maintains a significant interest through indirect holdings in SRB Investments LLC and Teaghlach LLC.
This executive disposed of 240 shares for about $343,000 on August 3. The sale was executed immediately following the exercise of 240 options with an exercise price of $720.81 per share.
The transaction involved the sale of 415 shares at $1,444.62 per share, representing an estimated value of about $599,517 on August 3. The disposition resulted from the immediate sale of shares acquired through the exercise of 415 stock options at a strike price of $397.95.
